The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment - Product Thumbnail Image

The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment

  • Report
  • 320 Pages
From
Immune Checkpoint Inhibitors: Clinical Trial Tracker - Product Thumbnail Image

Immune Checkpoint Inhibitors: Clinical Trial Tracker

  • Clinical Trials
From
Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 244 Pages
From
Therapies and Diagnostics for Ovarian Cancer: Global Markets to 2022 - Product Thumbnail Image

Therapies and Diagnostics for Ovarian Cancer: Global Markets to 2022

  • Report
  • 168 Pages
From
Drug Overview: Rubraca - Product Thumbnail Image

Drug Overview: Rubraca

  • Drug Pipelines
  • 29 Pages
From
Global Ovarian Cancer Drugs Market Research and Analysis - 2015-2022 - Product Thumbnail Image

Global Ovarian Cancer Drugs Market Research and Analysis - 2015-2022

  • Report
From
Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches - Product Thumbnail Image

Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches

  • Report
  • 126 Pages
From
Epithelial Ovarian Cancer: Disease and Pipeline Analysis - Product Thumbnail Image

Epithelial Ovarian Cancer: Disease and Pipeline Analysis

  • Report
  • 98 Pages
From
Ovarian Cancer - Pipeline Review, H2 2017 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H2 2017

  • Report
  • 2232 Pages
From
Fallopian Tube Cancer - Pipeline Review, H2 2017 - Product Thumbnail Image

Fallopian Tube Cancer - Pipeline Review, H2 2017

  • Report
  • 875 Pages
From
Ovarian Cancer - Pipeline Review, H1 2017 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2017

  • Report
  • 2027 Pages
From
Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 - Product Thumbnail Image

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • Report
  • 346 Pages
From
Epithelial Ovarian Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Epithelial Ovarian Cancer - Pipeline Review, H2 2016

  • Report
  • 507 Pages
From
Epithelial Ovarian Cancer - Pipeline Review, H1 2016 - Product Thumbnail Image

Epithelial Ovarian Cancer - Pipeline Review, H1 2016

  • Report
  • 479 Pages
From
Epithelial Ovarian Cancer - Pipeline Review, H2 2015 - Product Thumbnail Image

Epithelial Ovarian Cancer - Pipeline Review, H2 2015

  • Report
  • 450 Pages
From
Diffuse Diabetic Macular Edema Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Diffuse Diabetic Macular Edema Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 47 Pages
From
DNA Repair Drugs: Focus on PARP Inhibitors, 2016-2026 - Product Thumbnail Image

DNA Repair Drugs: Focus on PARP Inhibitors, 2016-2026

  • Report
  • 284 Pages
From
Peritoneal Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Peritoneal Cancer - Pipeline Review, H1 2018

  • Report
  • 1000 Pages
From
Ewing Sarcoma - Pipeline Insight, 2018 - Product Thumbnail Image

Ewing Sarcoma - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
PARP Inhibitors - A new class of targeted cancer therapies - Product Thumbnail Image

PARP Inhibitors - A new class of targeted cancer therapies

  • Report
  • 48 Pages
From
Loading Indicator
adroll